Updates in the Advancements of Pancreatic Surgery (Oncology Outreach Speaker Series) 10.1.19

October 1, 2019

The Updates in the Advancements of Pancreatic Surgery program is designed to develop an understanding of the importance of chemotherapy in pancreatic cancer.

Target Audience

Oncology Professionals

Learning Objectives

 

Updates in Pancreatic Cancer Surgery

• Develop understanding of the importance of chemotherapy in pancreatic cancer.

• Explain the rationale for pre-operative chemotherapy in pancreatic cancer.

• Recognize the role for robotic surgery in treatment of pancreatic cancer.

• Explain the importance of training in mastering Robotic Surgery.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 1.00 Attendance
Course opens: 
08/02/2019
Course expires: 
06/30/2020
Event starts: 
10/01/2019 - 7:00am EDT
Event ends: 
10/01/2019 - 5:00pm EDT
Add to calendar: 

Updates in the Advancements of Pancreatic Surgery”

 

Amer H. Zureikat, MD

Associate Professor of Surgery

Chief Division of Gastronintestial Surgical Oncology

Co-Director UPMC Pancreatic Cancer Center

University of Pittsburgh School of Medicine  

October 1, 2019

12:00 PM-1:00 PM

Indiana Hospital

Private Dining Room #1, (PDR #1)

 

Disclaimer Statement

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Indiana Hospital
PA
United States

Amer Zureikat, MD, Chief, Division of Gastrointestinal Surgical Oncology Co-Director, UPMC Pancreatic Cancer Center, Assistant Professor of Surgery, University of Pittsburgh School of Medicine

Faculty Disclosure

No members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any proprietary entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients to disclose.

 

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician (CME)

The University of Pittsburgh School designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 1.00 Attendance
Please login or register to take this course.